Ilsung Pharmaceuticals Co., Ltd. (003120.KS) KSC

25,550.00

+550(+2.20%)

Updated at September 09 02:41PM

Currency In KRW

Valuation

Market Cap105.65B
Enterprise Value-4.43B
P/E Ratio14.92
PEG Ratio-0.62
Price/Sales Ratio2.52
Price/Book Ratio0.46
Enterprise/Revenue0.84
Enterprise/EBITDA4.16

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.17
Operating Margin-0.09

Management Effectiveness

Return On Assets0.03
Return On Equity0.03

Income Statement

Revenue69.02B
Revenue/Share10,094.67
Gross Profit27.05B
EBITDA14.59B
Net Income13.09B
Diluted EPS1,920.8

Balance Sheet

Total Cash220.79B
Total Cash/Share32,411.4
Total Debt118.8M
Total Debt/Equity0
Current Ratio22.92
Book Value Per Share55,191.8

Price History

52-Week Change49.06
52-Week High31,450
52-Week Low14,500
Moving Average 50 Days24,958
Moving Average 200 Days18,764.35

Statistics

Average Volume37,665
Shares Outstanding6.82M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1,000
Trailing Annual Dividend Yield3.94
Payout Ratio0
Last Split Factor5:1
Last Split DateApril 17, 2023